Common Protocol: MK-677: 12.525 mg daily, oral, taken at night BPC-157: 250500 mcg daily, subcutaneous Cycle: 812 weeks for MK-677
Kleih M, Bpple K, Dong M, Gailer A, Heine S, Olayioye MA, Aulitzky WE, Essmann F (2019) Direct impact of cisplatin on mitochondria induces ROS production that dictates cell fate of ovarian cancer cells
Skin surveys showed that 75% of women reported an improvement in skin smoothness, 75% of women reported an improvement in overall skin health, 83% of women reported an improvement in how satisfied they were with how healthy their facial skin looked, and 83% of women were less bothered by how noticeable the lines on their face looked
Q11: Is this page medical advice
Supports focus, mood stability, and mental clarity through BDNF modulation